Limb-O™ Single Limb Anesthesia Breathing Circuit and Kits
Each Limb-O™ circuit is divided by a flexible septum running the length of the tube.
Limb-O™ effectively transfers heat from the expiratory to the inspiratory side of the circuit. Increased thermal efficiency rates during surgery keeps gases warm and body temperature normothermic.
Less weight means less torque on the ET tube and less plastic is being used. Decreased compliance helps lead to accurate delivered volume. Accomplish more with less as the single limb design services pediatric through adult patients. Limb-O™ as all Vyaire circuits are made without latex.
Please note that all products, services, or features of products and services may not be available in your local area. Please check with your local Vyaire representative.
Less plastic means less weight and torque on the patient’s airway management device; Limb-O™ weighs 34% less than coaxial circle circuits and 25% less than traditional circle circuits.
Limb-O™ weighs 25% less than traditional two-limb circuits which reduces torque on the patient’s airway.
Limb-O™ consolidates your inventory. The size of the lumen accommodates both adult and pediatric patients.
The presence of a septum in Limb-O™ decreases compliance in the circuit to significantly increase delivered volume without sacrificing drape.
Limb-O™’s low compliance tubing allows for delivery of a more accurate tidal volume.
Bench testing suggests the transfer of heat from the expiratory to the inspiratory limb of 6.2°C at 4L/min flow rates.
Limb-O™’s common wall/septum separating inspiratory and expiratory lumens permits heat transfer from warm exhaled gasses.
The Latest News From Vyaire
“As the leading manufacturer of solutions for the treatment and monitoring of respiratory conditions at every stage of life, Vyaire Medical has been working tirelessly to deliver our ventilator equipment for patients in respiratory distress due to COVID-19, and to the healthcare workers treating
Read MoreCHICAGO – April 3, 2020 – Vyaire Medical, Inc. and CEO Gaurav Agarwal today issued the following update on the company’s response to the coronavirus (COVID-19) pandemic:
Read More